Hypoxic-ischemic Encephalopathy (HIE)
Neurology·MeSH: Hypoxia-Ischemia, Brain
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Dobutamine | ENANTA PHARMACEUTICALS INC (ENTA) |
Frequently asked questions
How many drugs are in development for Hypoxic-ischemic Encephalopathy (HIE)?
BioSniper tracks 1 drug in development for Hypoxic-ischemic Encephalopathy (HIE) across 1 company.
How many clinical trials target Hypoxic-ischemic Encephalopathy (HIE)?
There are 1 clinical trial targeting Hypoxic-ischemic Encephalopathy (HIE) tracked by BioSniper.
Deep-dive into Hypoxic-ischemic Encephalopathy (HIE)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis